CoSolve Challenges
Discovering the next big idea, application or technology in healthcare
CoSolve challenges are currently closed. However, new challenges will soon be announced – sign up to our newsletter to be the first to hear about them.
What is CoSolve?
CoSolve is a biannual, global Open Innovation programme seeking collaborators with innovative solutions to real research challenges. These challenges lie within our R&D research focus areas and require solutions that are immediately translatable. We are looking for collaborators from start-ups and early stage biotechs with expertise in these specialised areas, who can bring innovative ideas that can be rapidly translated into tangible solutions. Working together, your ideas could help shape the development and delivery of new therapies and bring them to patients sooner.
Programme details
Submission status: Closed
Next submission to open late 2021.
- Collapse all
CoSolve is focused on accelerating the development of new therapies for patients in the greatest need. We are looking for innovative solutions that can be translated into practice within a 12–18-month timeframe.
CoSolve will give you access to our knowledge and resources, helping develop your ideas into possible future advances in life-changing medicines. You will be working side-by-side with some of our top experts across our R&D focus areas and drug discovery and development.
We are seeking collaborators, ideally from start-ups and early-stage biotech companies, with expertise to address specific CoSolve challenges. Successful collaborators must have the ability and freedom of operation to accelerate their idea into a fully translatable, tangible solution with support from AstraZeneca.